Skip to main content
Xlife Sciences AG logo

Xlife Sciences AG — Investor Relations & Filings

Ticker · XLS ISIN · CH0461929603 LEI · 984500AH590BE88BB517 SW Professional, scientific and technical activities
Open in API
Filings indexed 287 across all filing types
Latest filing 2021-06-03 Director's Dealing
Country CH Switzerland
Listing SW XLS

About Xlife Sciences AG

https://www.xlifesciences.ch/en/home

Xlife Sciences AG is a life sciences company that specializes in the value development and commercialization of early-stage research projects. The company identifies promising technologies from universities and other research institutions, acting as an incubator and accelerator to bridge the gap between academic research and healthcare markets. Its operations are focused on four core areas: technology platforms, biotechnologies and therapies, medical technology (health technology), and the application of artificial intelligence in life sciences and digital health. The primary objective is to develop solutions that address high unmet medical needs and improve quality of life.

Recent filings

Filing Released Lang Actions
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section header 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a transaction (Acquisition) by an individual named Oliver R. Baumann, identified as a 'Member of the managing body' of Xlife Sciences AG. This content directly matches the definition for Director's Dealing reports.
2021-06-03 English
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the transaction (Acquisition), the person involved (Oliver R. Baumann, Member of the managing body), the instrument (Share), and the date/price. This directly corresponds to the definition of Director's Dealing.
2021-05-20 English
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of an individual (Oliver R. Baumann), their position ('Member of the managing body'), the nature of the transaction ('Acquisition'), the financial instrument (Share), and the date and location of the transaction. This content directly matches the definition for Director's Dealing.
2021-05-20 English
Xlife Sciences AG: Xlife ist neu im MSCI Word Micro Cap Index und erhalt weiter Publizitat (News mit Zusatzmaterial)
Regulatory Filings Classification · 1% confidence The document is a short corporate announcement dated May 17, 2021, distributed via DGAP (a service often used for regulatory news). The content discusses Xlife Sciences AG being included in the MSCI World Micro Cap Index, being featured as a 'Hot Deal' in 'Börse Online', and an interview with the CEO. It is not a full financial report (like 10-K or IR), nor is it a specific announcement about dividends, director dealings, or capital changes. It is a general update about company publicity and index inclusion. Given its nature as a general corporate news item distributed through a regulatory news service (DGAP), and lacking a more specific category like ER, CT, or DIV, the most appropriate fallback category is Regulatory Filings (RNS), as it serves as a general regulatory announcement.
2021-05-17 German
Xlife Sciences AG: Portfolio project listed on the Stock Exchange
Regulatory Filings Classification · 1% confidence The document is a press release dated May 14, 2021, announcing that a portfolio project of Xlife Sciences AG, Vitruvia Medical AG, has been listed on the Munich Stock Exchange. This announcement details a significant corporate action related to the structure and valuation of a company asset, specifically an Initial Public Offering (IPO) or listing of a subsidiary/project. This event falls under corporate financing or capital structure changes, as it involves the public trading of shares for a related entity, leading to a higher valuation for the parent company. While it is an announcement, it is more specific than a general 'Report Publication Announcement' (RPA) or 'Regulatory Filing' (RNS). It directly relates to capital market activity. The most fitting category is 'Capital/Financing Update' (CAP), as it announces the successful listing and initial pricing of a new equity instrument/company.
2021-05-14 English
Xlife Sciences AG: Borsennotierung einer Projektgesellschaft
Share Issue/Capital Change Classification · 1% confidence The document is a 'MEDIENINFORMATION' (Media Information) from Xlife Sciences AG announcing that its project company, Vitruvia Medical AG, has been listed on the Munich stock exchange ('Börsennotierung einer Projektgesellschaft'). This announcement details a significant corporate event related to the capital structure and listing of an associated entity, which falls under financing activities or capital structure changes. Since it is an announcement about a listing/capital event rather than a standard periodic financial report (10-K, IR, ER) or a formal regulatory filing like a Director's Dealing or Major Shareholding notification, the most appropriate category is 'Capital/Financing Update' (CAP). It is not a general regulatory filing (RNS) because it fits a more specific category, and it is not an announcement of a report (RPA) as it is reporting a specific corporate action.
2021-05-12 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.